12.04.2010
Congenix is pleased to announce that Mr. Luis D. Encarnacion joined our company bringing more than 8 years of business development experience... more

25.02.2010
Congenix is pleased to announce that they have been chosen to participate in a Phase II study for the treatment of rheumatoid arthritis with the use of monoclonal antibodies... more